Compositions and methods for augmenting the nasal microbiome
US11406671B2 · kind B2 · utility
2Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2016 |
| Grant date | Aug 9, 2022 |
| Priority date | — |
| Expiry date | Apr 25, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Embodiments of the invention provide a method of reducing colonization of a subject's anterior nares and/or nasal cavity by a microorganism (e.g., Staphylococcus aureus). In some aspects, the method may include administering a pharmaceutical composition to the subject, wherein the pharmaceutical composition comprises a therapeutically effective amount of at least one probiotic.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.